Tripartite Meeting:
SEMI (Sociedad Española de Medicina Interna),
CEF (Capítulo
Español de Flebología)
SEACV (Sociedad Española de Angiología y Cirugía Vascular)
Cancer and DVT
Chairman: José Román Escudero (Spain)
09.00-09.10
Introduction
Francisco Lozano (Spain)
09.10–09.25
Occult cancer.
Javier Trujillo (Spain)
09.25–09.40
Cancer and DVT of the upper limbs.
Andrea Piccioli (Italy)
09.40–09.55
Prophylaxis of patients with reservoirs.
Antonio Romera (Spain)
09.55–10.10
Long term therapy LMWH vs Oral anticoagulants.
Teresa Solanich (Spain)
10.10 –10.30
Discussion.
Ramón Pujol (Spain)
10.30–11.00
Coffee Break and visit to exhibition
11.00–13.00
Live Cases Session
Four patients with venous disease will be presented. Ultrasonic examination will then be performed by Nicos Labropoulos and Juan Fontcuberta. Discussion will take place with
the experts on the optimum treatment for each patient.
Chair: Marc Cairols and Antonio Romera
The pitfalls of venous duplex imaging. Maura Griffin (UK)
Live Session: Nicos Labropoulos, Juan Fontcuberta,
Dimitri Kontothasnassis,
Manuel Miralles
13.00–15.00
Lunch and EVF Board Meeting (Board members only)
15.00–16.30
Didactic Session supported by an educational grant from Servier Venous Valve inflammation: A new target for drugs
Chairpersons: P. Carpentier (France) - M. Cairols (Spain)
15.00
Introduction
M Cairols (Spain)
15.05-15.25
Venous valve and venous pain in chronic venous disease.
AN Nicolaides (Cyprus)
15.25-15.45
New investigations for venous valve insufficiency: Perspectives for early detection.
F Lurie (USA)
15.45-16.05
Animal models for the study of venous valve insufficiency. The role of Daflon 500 mg.
G Schmid-Schönbein (USA)
16.05-16.25
Efficacy of Daflon 500 mg on venous pain: Results and perspectives. A Jawien (Poland)
16.25
Conclusion.
P Carpentier (France)
16.30–17.00
Coffee Break
17.00–18.30
Special session on Chronic Venous Disease (CVD): Endotherapy for CVD
Chair: Hugo Ballón (Spain) – Marc Cairols (Spain)
17.00–17.15
Is foam sclerotherapy safe?
Lorenzo Tessari (Italy)
17.15–17.30
Is radiofrequency the option for CVF?
Bruce Braithwaite (UK)
17.30–17.45
Is endolaser the future?
Attilio Cavezzi (Italy)
17.45-18.00
One year follow-up. Radiofrequency segmental thermal ablation (RTFA) of great saphenous veins
Olivier Pichot (France)
18.00-18.30
Discussion
César Garcia Madrid (Spain)
19.00
Welcome reception
Exhibitor area
Friday, 27th June, 2008
08.30-10.30
Scientific Session I:Compression Therapy
Chair: Josep Marinel.lo, Andrew Nicolaides,
08.30
1.1
Symptoms relief after compressive therapy can predict results of surgical treatment of chronic venous disease limited to superficial and perforating vein reflux.
Lurie F, Kistner RL, Ly C, Akamine J. Kistner Vein Clinic and University of Hawaii, Honolulu, Hawaii, USA
08.50
1.2
Dose-response relationship in randomized clinical studies of compression therapy for venous insufficiency oedema.
Partsch H1, Vanscheidt W2, Ukat A2. 1University of Vienna, Vienna, Austria. 2Dermatologische Praxisgemeinschafts, Freiburg, Germany
09.10
1.3
Inelastic compression increases venous ejection fraction more than elastic bandages. Mosti G*, Mattaliano V*, Partsch H**. *Angiology Department; Clinica M.D, Barbantini; Lucca, Italy, **Private Practice; Vienna, Austria
09.30
1.4
Evaluation of clinical effectiveness of two- and four-layer compression in venous leg ulcer treatment - randomized study
Jawien A1, Szewczyk MT1, 2, Mościcka P2, Cierzniakowska K1,2, Cwajda J2. 1Katedra i Klinika Chirurgii Ogólnej Collegium Medicum UMK Bydgoszcz, Poland, 2Zakład Pielęgniarstwa Chirurgicznego Collegium Medicum UMK Bydgoszcz, Poland
09.50
1.5
Endoscopically assisted greater saphenous vein stripping. A prospective randomized trial.
Assadian A1, Wickenhauser G1, Senekowitsch C1, Hagmüller GW1. 1Department of General and Vascular Surgery, Wilhelminenspital Vienna, 2Department of Laboratory Medicine, Wilhelminenspital Vienna
10.10
1.6
Importance of the varicose reservoir for the mid-term results of the surgical treatment of varices by phlebectomy with conservation of a refluxing saphenous vein.
Pittaluga P1, Chastanet S1, Rea B2, Barbe R2, Guex J-J3. 1Riviera Veine Institut, Nice, France, d’Ostende, Monaco, 2Clinique Charcot, Ste-Foy-lès-Lyon, France, 3Cabinet de Médecine Vasculaire, Nice, France
10.30–11.00
Coffee break and visit to exhibition
11.00–12.30
Didactic Session supported by an educational grant from Medi Bayreuth. Compression after surgery and endovenous procedures workshop
Chair: Hugo Partsch, Marc Cairols
11.00-11.15
What is the actual evidence for compression after venous procedures?
Eberhard Rabe (Germany)
11.15-12.00
How we do it after conventional stripping, sclerotherapy and after laser ablation and
other endovascular procedures?
Attilio Cavezzi (Italy), Javier Leal Monedero (Spain),
Jean-Patrick Benigni (France), Josep Marinel.lo (Spain),
Marianne de Maeseneer
(Belgium)
12.00-12.15
The problem to compress veins on the thigh.
Hugo Partsch (Austria), Giovanni Mosti (Italy)
12.15-12.30
Our solution for effective thigh compression.
Oscar Maleti (Italy), Marzia Lugli (Italy)
Discussion
12.30–13.00
EVF Invited Lecture
Current transitions in anti-coagulant therapies. Are heparins and oral anticoagulants challenged?
Jawed Fareed (USA)
13.00 – 14.30
Lunch
14.30-15.10
Presentations from American Venous Forum winners of the Servier Travelling Fellowship
Chair: Marc Cairols, Joe Caprini
14.30 1.7
Lower extremity arterial inflow is adversely affected in patients with post-thrombotic venous disease.
Paolini D, Jones L, Comerota AJ. The Toledo Hospital, Toledo, OH, USA
14.50 1.8
The quantitative benefit of isolated, segmental, pharmacomechanical thrombolysis for iliofemoral DVT
Martinez J, Comerota AJ, Kazanjian S, DiSalle R, Sepanski DM, Assi ZI. The Toledo
Hospital, Toledo, OH, USA
15.10–17.10
Scientific Session II: Diagnosis of Venous Disease Chair: Cesar Garcia Madrid, Alun Davies
15.10
2.1
Impedance and duplex haemodynamic parameters modifications induced by haemodynamic correction type 1 (CHIVA 1).
Tacconi G, Menegatti E, Fortini P, Legnaro A, Gianesini S, Zamboni P. Vascular Disease Center, University of Ferrara, Italy.
15.30
2.2
Upper limb DVT: Is it a high risk marker for neoplasia?
Martínez Ruiz E, Romera Villegas A, Santos Espí M, Cairols Castellote MA. Angiology and Vascular Surgery Department, Hospital Universitari de Bellvitge,
L’Hospitalet de Llobregat, Barcelona, Spain
15.50
2.3
Progression of chronic venous disease in post-thrombotic limbs is more rapid when compared to primary.
Gasparis AP1, Labropoulos N1, Pefanis D2, Leon LR3, Psalms SB3, TassiopoulosAK1. 1Division of Vascular Surgery, Stony Brook University Medical Center, Stony Brook, NY, USA. 2Division of Vascular Surgery, University of Medicine and Dentistry, Newark, NJ, USA. 3Vascular Surgery Section, University of Arizona Health Science Center, Tucson, AZ, USA
16.10
2.4
Prevalence of fatal pulmonary embolism in hospital population for the 35 year old period.
Baeshko AA, Tsikunova AA, Rogov YI, Zhuk HV, Vartanyan VF, Krijova EV, Lopuhov OV, Dechko VM. Belorussian State Medical University, 9th City Clinical Hospital, Minsk, Republic Belarus
16.30
2.5
Does corona phlebectatica indicate chronic venous insufficiency?
Rabe E, Pannier F. Department of Dermatology, University of Bonn, Germany
16.50
2.6
Validity of duplex-ultrasound in identifying the cause of groin recurrence after varicose vein surgery.
Geier B, Mumme A, Hummel T, Marpe B, Freis H, Stücker M, Asciutto G. Vein Center, Department of Vascular Surgery and Department of Dermatology, St.Josef-Hospital, Ruhr-University Bochum, Germany
Obstructed A-V fistula as a model of chronic venous insufficiency
Murphy MA, Gemmill E, Darby C, Hands LJ. University of Oxford and Oxford Radcliffe Hospitals, Oxford, UK
18.00
3.2
Klippel-Trenaunay syndrome: Is there evidence of a functional arterial leg inflow impairment?
Delis KT1, Gloviczki P1, Wennberg P2, Bjarnason H3 , Rooke T2, Driscoll DJ4. Divisions of Vascular Surgery,1 Vascular Medicine,2 Interventional Radiology,3 Pediatric Cardiology,4 Mayo Clinic, Rochester, MN, USA
18.20
3.3
Assessment of quality of life in patients with varicose veins: What are the options?
Shepherd AC, Gohel MS, Hamish M, Lim CS, Davies AH. Imperial Vascular Unit, Imperial College, Charing Cross Hospital, London. UK
18.40
3.4
Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis?
Romera-VillegasA, Vila-Coll R, Cairols M, Martinez-Rico C. Hospital Universitari de Bellvitge, L'Hospitalet Llobregat, Barcelona, Spain
19.00
3.5
Over-expression of aFGF in the wall of varicose veins. A link to the disease pathogenesis.
Kowalewski R 1, Malkowski A 2, Sobolewski K 2, Gacko M 1. Department of Vascular Surgery and Transplantology 1, Department of Medical Biochemistry 2, Medical University, Bialystok, Poland
19.20
3.6
Prognostic signification of venous symptoms in the Basel venous study. Carpentier PH1, Widmer M-T2, Zemp E3, Uhl J-F1, Cornu-Thénard A1. 1Groupe Insuffisance Veineuse Chronique de la Société Française de Médecine Vasculaire (France), 2Abteilung für Angiologie and 3Institut für Sozial- und Präventivmedizin, Universität Basel (CH)
19.45
Annual General Assembly
20.30
Conference Dinner
Masia Egara
Saturday, 28th June, 2008
08.30–10.30
Scientific Session IV: Endo & Minimally Invasive Treatment
Chair: Manuel Miralles, Mehmet Kurtoglu
08.30
4.1
The Bilateral Laser and Radiofrequency Ablation (BLARA) Trial.
Goode S, Crockett M, Richards T, Braithwaite B., Chowdhury A.
Queens Medical Centre and Mapperley Park Clinic, Nottingham, UK
08.50
4.2
Preliminary experience with concomitant ultrasound-guided foam sclerotherapy and endovenous laser ablation: A series of 1000 consecutive cases.
King T. Vein Clinics of America, Oak Brook, IL, USA
09.10
4.3
New endovenous therapies of lower extremity varicosities are at least as effective as surgical stripping and sclerotherapy: Meta-analysis and meta-regression of case series and randomized clinical trials. Van den Bos R, Kockaert M, Neumann M, Nijsten T. Erasmus Medical Centre, Rotterdam, The Netherlands
09.30
4.4
Ultrasound guided foam sclerotherapy combined with sapheno-femoral ligation VERSUS surgical treatment of varicose veins: intermediate results OF A Randomised controlled trial. Kalodiki E, Azzam M, Kakkos SK, Zambas N, Bountouroglou D, Geroulakos G. Josef Pflug Vascular Laboratory and the Vascular Unit, Ealing Hospital, Department of Vascular Surgery, Imperial College, London, UK
09.50
4.5
Saphenectomy of the GSV without crossectomy: 5 years follow-up in a randomized study in 124 legs with terminal valve reflux.
Casoni P. Casa di Cura Citta’ di Parma - Sezione Chiirurgia Vascolare, Parma, Italy
*Molding Clinic - Department of Phlebology, Marbella - Spain
10.10
4.6
Randomized clinical trial on surgical techniques for the treatment of varicose veins in legs: Non conservative treatment compared to a conservative one (CHIVA). Five years followup. Parés O, Juan J, Moreno C, éllez R, Codony I, Mata A, Quer X, Roca J. Angiology and Vascular Surgery Unit at The Hospital General de Vic, Spain
10.30–11.00
Coffee Break and visit to the exhibition
11.00–12.00
Invited Presentations
Chair: M. Monreal (Spain) - Jawed Fareed (USA)
11.00–11.15
The efficacy of single daily dose of enoxaparin treatment in acute venous thromboembolism: Tromboket study.
M Kurtoglu (Turkey)
11.15–11.30
Evidence based guidelines versus clinical practice guidelines.
J Caprini (USA)
11.30–11.45
RIETE Registry.
M. Monreal (Spain)
11.45–12.00
International Venous Registry.
A. Davies (UK)
12.00-12.15
The computerised venous registry. A tool for venous studies.
A Cornu-Thenard (France)
12.15-14.15
Scientific Session V: Chronic Venous Disease: Endovascular Therapy
Chair: Rosa Moreno, Michel Perrin
12.15
5.1
Endovenous laser treatment: A morphological study in an animal model.
Vuylsteke M (a), Van Dorpe J (b), Roelens J (c), Mordon S (d).
Department of Vascular Surgery Sint-Andriesziekenhuis Tielt Belgium
Department of Pathology Heilig-Hartziekenhuis Roeselare Belgium
Department of Pathology Sint-Andriesziekenhuis Tielt Belgium
INSERM IFR 114, Lille University Hospital, 59037 Lille, France (SM).
12.35
5.2
Foam sclerotherapy of saphenous veins with or without medical-support stocking (compression). Biological effects of foam sclerotherapy. Randomized study.
Hamel-Desnos CM1, Guias B2, Quéhé P2, Mesgard A3, Desnos P4, Ferre B5, Le Querrec A5. 1Saint Martin Private Hospital Center, Caen, France, 2Brest-University Hospital Center, France, 3Morlaix, France, 4Caen, France, 5Caen, University Hospital Center, France
12.55
5.3
Side effects and complications of foam sclerotherapy of the great and small saphenous veins : a controlled multicentre prospective study including 1025 patients
Gillet JL, Guedes JM, Guex JJ, Hamel-Desnos C, Schadeck M, Lauseker M, Allaert FA, Vascular Medicine-Phlebology, Jallieu, France
13.15
5.4
Chemical Ablation of Primary Varicose Veins under controlled ischemia : Advantages, Technique and Results. Updated 6 Six Years Experience. Magdiel Trinidad V*, Magdiel Trinidad H**, Leonel Villavicencio J **. Department of Surgery Hospital del Carmen, Guadalajara, Jal. Mexico*, Department of Surgery, Masonic Hospital Chicago. IL**, Uniformed Services University of the Health Sciences, Bethesda, MD*** , USA
13.35
5.5
Investigating the cost of traditional and endovenous treatments for unilateral and bilateral varicose veins: A decision tree analysis.
MS Gohel, A Shepherd, CS Lim, M Hamish, AH Davies. Department of Vascular Surgery, Charing Cross Hospital, London, UK
13.55
5.6
Sclerotherapy: A study using Polidocanol, comparing foam form and liquid form.
Uncu H. Faculty of Medicine, Department of General Surgery, Ankara University, Ankara, Turkey
